Search Results

There are 8851 results for: content related to: Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS

  1. You have free access to this content
    Poster Presentations by Authors from A-Z (alphabetical order)

    Neurogastroenterology & Motility

    Volume 27, Issue S2, June 2015, Pages: 37–109,

    Version of Record online : 31 MAY 2015, DOI: 10.1111/nmo.12598

  2. You have free access to this content
    Validating biomarkers of treatable mechanisms in irritable bowel syndrome

    Neurogastroenterology & Motility

    Volume 26, Issue 12, December 2014, Pages: 1677–1685, M. Camilleri, A. Shin, I. Busciglio, P. Carlson, A. Acosta, A. E. Bharucha, D. Burton, J. Lamsam, A. Lueke, L. J. Donato and A. R. Zinsmeister

    Version of Record online : 22 SEP 2014, DOI: 10.1111/nmo.12421

  3. You have free access to this content
    Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission

    Neurogastroenterology & Motility

    Volume 25, Issue 9, September 2013, Pages: 756–e578, B. Jonefjäll, H. Strid, L. Öhman, J. Svedlund, A. Bergstedt and M. Simren

    Version of Record online : 4 JUN 2013, DOI: 10.1111/nmo.12163

  4. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  5. You have free access to this content
    The quest for biomarkers in IBS—where should it lead us?

    Neurogastroenterology & Motility

    Volume 26, Issue 12, December 2014, Pages: 1669–1676, M. Corsetti, L. Van Oudenhove and J. Tack

    Version of Record online : 25 NOV 2014, DOI: 10.1111/nmo.12475

  6. You have free access to this content
    Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1

    Neurogastroenterology & Motility

    Volume 27, Issue 1, January 2015, Pages: 82–91, A. Shiotani, H. Kusunoki, M. Ishii, H. Imamura, N. Manabe, T. Kamada, J. Hata, J. L. Merchant and K. Haruma

    Version of Record online : 27 NOV 2014, DOI: 10.1111/nmo.12473

  7. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 2, July 2016, Pages: 181–188, K. Diederen, D. R. Hoekman, T. Z. Hummel, T. G. de Meij, B. G. P. Koot, M. M. Tabbers, A. M. Vlieger, A. Kindermann and M. A. Benninga

    Version of Record online : 25 APR 2016, DOI: 10.1111/apt.13636

  8. You have free access to this content
    Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome

    Neurogastroenterology & Motility

    Volume 26, Issue 4, April 2014, Pages: 455–469, Y. Nasser, G. E. Boeckxstaens, M. M. Wouters, M. Schemann and S. Vanner

    Version of Record online : 14 FEB 2014, DOI: 10.1111/nmo.12316

  9. Sleep disturbances in irritable bowel syndrome: a systematic review

    Neurogastroenterology & Motility

    Q. Tu, M. M. Heitkemper, M. E. Jarrett and D. T. Buchanan

    Version of Record online : 28 SEP 2016, DOI: 10.1111/nmo.12946

  10. You have free access to this content
    Poster Presentations

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S3, October 2013, Pages: 23–693,

    Version of Record online : 17 SEP 2013, DOI: 10.1111/jgh.12363_2

  11. You have free access to this content
    Irritable bowel syndrome: an integrated explanatory model for clinical practice

    Neurogastroenterology & Motility

    Volume 27, Issue 6, June 2015, Pages: 750–763, A. P. S. Hungin, A. Becher, B. Cayley, J. J. Heidelbaugh, J. W. M. Muris, G. Rubin, B. Seifert, A. Russell and N. J. De Wit

    Version of Record online : 20 FEB 2015, DOI: 10.1111/nmo.12524

  12. You have free access to this content
    An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease

    Neurogastroenterology & Motility

    Volume 25, Issue 11, November 2013, Pages: 918–e704, J. W. Berrill, J. Gallacher, K. Hood, J. T. Green, S. B. Matthews, A. K. Campbell and A. Smith

    Version of Record online : 26 AUG 2013, DOI: 10.1111/nmo.12219

  13. You have free access to this content
    Abstracts

    Journal of Gastroenterology and Hepatology

    Volume 31, Issue S3, November 2016, Pages: 7–441,

    Version of Record online : 19 OCT 2016, DOI: 10.1111/jgh.13540

  14. You have free access to this content
    The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 8, April 2013, Pages: 786–794, C. Lahiff, P. Safaie, A. Awais, M. Akbari, L. Gashin, S. Sheth, A. Lembo, D. Leffler, A. C. Moss and A. S. Cheifetz

    Version of Record online : 21 FEB 2013, DOI: 10.1111/apt.12262

  15. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  16. You have free access to this content
    Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 7, October 2007, Pages: 1035–1042, O. SCHRÖDER, M. NAUMANN, Y. SHASTRI, N. POVSE and J. STEIN

    Version of Record online : 28 JUL 2007, DOI: 10.1111/j.1365-2036.2007.03457.x

  17. You have free access to this content
    On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens

    Neurogastroenterology & Motility

    Volume 26, Issue 2, February 2014, Pages: 156–167, M. Grover, M. Camilleri, K. Smith, D. R. Linden and G. Farrugia

    Version of Record online : 19 JAN 2014, DOI: 10.1111/nmo.12304

  18. You have free access to this content
    Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 1, July 2013, Pages: 44–51, J. W. Berrill, J. T. Green, K. Hood and A. K. Campbell

    Version of Record online : 13 MAY 2013, DOI: 10.1111/apt.12335

  19. You have free access to this content
    Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 11-12, December 2012, Pages: 1009–1031, J. Matricon, M. Meleine, A. Gelot, T. Piche, M. Dapoigny, E. Muller and D. Ardid

    Version of Record online : 15 OCT 2012, DOI: 10.1111/apt.12080

  20. Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome

    Neurogastroenterology & Motility

    Volume 28, Issue 7, July 2016, Pages: 1094–1103, M. E. Jarrett, C. J. Han, K. C. Cain, R. L. Burr, R. J. Shulman, P. G. Barney, B. D. Naliboff, J. Zia and M. M. Heitkemper

    Version of Record online : 19 MAR 2016, DOI: 10.1111/nmo.12812